Bizarre Patents
A helium-filled sun shade for protecting individuals engaged in outdoor activities.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8114856 | Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection. ... | 02/14/2012 |
| 8114855 | Low density cosmetic formulations, cosmetic products containing the same and methods of treating hair, nails and/or skin using the same Low density cosmetic formulations which comprise: (a) a cosmetic mixture; and (b) a gas incorporated in the cosmetic mixture; wherein the cosmetic mixture comprises (i) an alk(en)ylpolyglycoside, (ii) a quaternary ammonium polymer, and (iii) a thickener, are describ... | 02/14/2012 |
| 8110561 | Injectable cross-linked polymeric preparations and uses thereof A therapeutic composition for treatment of a body tissue which includes an aqueous solution of a cross-linked polymer being capable of: (i) maintaining a liquid state in storage at room temperature for at least 24 hours; and (ii) assuming a gel state following depos... | 02/07/2012 |
| 8084440 | Method for improving the fertility of animals This invention is in the field of animal food, in particular food for female animals in their reproductive phase. Food according to the invention improves the fertility of animals and increases their chances on a pregnancy. It was found that the fertility of animals... | 12/27/2011 |
| 8084441 | Cystitis treatment with high dose chondroitin sulfate Interstitial cystitis and related GAG-deficient conditions of the bladder and urinary tract are treated by instillation of high dose chondroitin sulfate, such as 400 mg/20 mL. The higher dose of chondroitin is effective for the rapid reduction of symptoms, particula... | 12/27/2011 |
| 8080535 | Hyaluronic acid nutritional supplements and methods of using the same Hyaluronic acid nutritional supplements and methods of using the same. In at least one embodiment of a nutritional supplement of the present disclosure, the nutritional supplement comprises a quantity of a hyaluronic acid, or a salt or digest thereof, and a food acc... | 12/20/2011 |
| 8076312 | Use of lipid conjugates in the treatment of disease This invention provides a method of preventing asthma, allergic rhinitis, or chronic obstructive pulmonary disease in a subject comprising the step of administering to a subject a compound comprising a lipid or phospholipid moiety bond to a physiologically acceptabl... | 12/13/2011 |
| 8076314 | Topical compositions for anti-aging and methods of using same A pharmaceutical composition for treatment of skin aging including a pharmaceutically effective amount of estriol; a pharmaceutically effective amount of estradiol; a pharmaceutically effective amount of hyaluronic acid; a pharmaceutically effective amount of green ... | 12/13/2011 |
| 8076313 | Composition containing fermentable polysaccharides The present invention relates to a composition to a nutritional composition comprising 0.1 to 15 gram fermentable e partially hydrolysed gum having a degree of polymerization between 10 and 300 per 100 gram dry weight of the composition and 0.1 to 15 gram fermentabl... | 12/13/2011 |
| 8063026 | Method of palliating lower urinary tract infections by treatment with mannan oligosaccharides Provided herein are methods of using mannan oligosaccharides, to treat, palliate, relieve, prevent and/or eliminate urinary tract infections of humans. A mixture of oligosaccharides derived from yeast cell walls is shown to reduce, eliminate and prevent the symptoms... | 11/22/2011 |
| 8039448 | N-acylated chitinous polymers and methods of use thereof The invention pertains to N-acetylated, N, O-carboxyalkylchitosans and methods for using the chitosans to treat disorders, such as cancer, nervous system disorders, urinary tract disorders, and reproductive tract disorders. ... | 10/18/2011 |
| 8039447 | Derivatives of hyaluronic acid, their preparation process and their uses The present invention relates to the use of a compound having the formula (I) wherein: n represents an integer varying from 720 to 6 200, and i varies from 1 to n, Ri represents in particular OH, or a group of the formula (III) wherein k represents an int... | 10/18/2011 |
| 8034795 | Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives The present invention relates to water-soluble taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives, and in particular to paclitaxel and docetaxel, useful for the preparation of pharmaceutical compositions to be used in the field of oncology,... | 10/11/2011 |
| 8022049 | Polysaccharide produced by microorganism belonging to genus A polysaccharide comprising galactose, glucose, rhamnose, and pyruvic acid as constituents, wherein the galactose, glucose, and rhamnose are contained in a molar ratio of 4:2:1, and the pyruvic acid is contained in an amount of 4 to 7 wt %. The polysaccharide can be... | 09/20/2011 |
| 8008276 | Use of zwitterionic polysaccharides for the specific modulation of immune processes The invention relates to three-dimensional molecular structure determination of polymers, three-dimensional computer molecular modeling, rational drug design, and immunomodulatory polymers. In particular the invention is directed to immunomodulatory polymers, as wel... | 08/30/2011 |
| 8008275 | Fucose containing proteoglycan or acidic glycan and their pharmaceutical use A class of proteoglycans containing fucosylated acidic glycans, e.g., as produced by marine sponges and sea urchin embryos, have been found to stimulate selective proliferation of mammalian natural killer (NK) cells and γδT cells. These compounds are useful as pha... | 08/30/2011 |
| 7998942 | Eye drop preparation comprising xanthan gum and terpenoid The present invention provides an ophthalmic solution containing xanthan gum and terpenoid, which shows a suppressed decrease in the terpenoid content, by the addition of xanthan gum to an ophthalmic solution containing terpenoid. ... | 08/16/2011 |
| 7981871 | Modified macromolescules and associated methods of synthesis and use Described herein are compounds such as macromolecules that have been modified in order to facilitate crosslinking by introduction of at least one hydrazide-reactive group and/or aminooxy-reactive group, and methods of making and using thereof for scar-free wound hea... | 07/19/2011 |
| 7973021 | Immunomodulating agent in gut An object of the present invention is to provide an immunomodulating agent in gut that can be ingested continuously in daily diet without adverse side effect. The object is attained by providing an immunomodulating agent in gut comprising a cyclic tetrasaccharide as... | 07/05/2011 |
| 7956045 | Compositions and methods for animal treatment A method of improving the health and production of ruminant animals, the method including the step of orally administering to the animal an effective amount of an indigestible oligosaccharide selected from the group of gluco-oligosaccharides and isomalto-oligosaccha... | 06/07/2011 |
| 7956047 | Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation The present invention comprises the use of chondroitin sulphate (CS-E) or an active fragment thereof for the treatment of diseases or conditions related to collagen fibril formation. Said compounds can be administrated either by oral, topical, injectable or by any o... | 06/07/2011 |
| 7956046 | Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them Oligosaccharide mixtures comprising anti-Xa activities of from 190 IU/mg to 450 IU/mg and anti-IIa activities of less than 0.2 IU/mg; and having constituent oligosaccharides with an average molecular weight of from 1800 to 2400 Daltons, constituent oligosaccharides ... | 06/07/2011 |
| 7943595 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative The present invention relates to novel synthetic polysaccharides with antithrombotic activity exhibiting at least one covalent bond with biotin or a biotin derivative and to a process employing avidin or streptavidin which makes it possible to neutralize these polys... | 05/17/2011 |
| 7943594 | Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans One aspect of the present invention relates to solution-phase approaches to GPI synthesis. Another aspect of the present invention relates to key building blocks, and syntheses thereof, useful for GPI assembly. Yet another aspect of the invention relates to an autom... | 05/17/2011 |
| 7943596 | Medicinal composition for ophthal use containing acetylated hyaluronic acid The present invention provides an ophthalmic pharmaceutical composition containing acetylated hyaluronic acid and a pharmacologically acceptable carrier. Preferably, the average molecular weight of the acetylated hyaluronic acid is 10,000 to 1,000,000, and the acety... | 05/17/2011 |
| 7939511 | Ophthalmic composition containing xanthan gum and amino acid The present invention provides an ophthalmic composition containing xanthan gum, or xanthan gum and an amino acid, which has a superior corneal epithelial disorder-treating effect and a superior corneal epithelial cell-protecting effect. ... | 05/10/2011 |
| 7935682 | Wound healing dressing for enhancing fibrocyte formation The present invention relates to the ability of SAP to suppress the differentiation of monocytes into fibrocytes. It also relates to the ability of IL-4 and IL-3 to enhance the differentiation of monocytes into fibrocytes. Methods and compositions for binding SAP, d... | 05/03/2011 |
| 7935683 | Polysaccharide-carbon nanotube complex Disclosed is a complex which comprises a carbon nanotube and a modified polysaccharide having a backbone chain with the side thereof being introduced with monosaccharide or oligosaccharide residues. The polysaccharide is preferably β-1,3-glucan. The complex is prep... | 05/03/2011 |
| 7935684 | Method for treating allergic diseases The present invention relates to use of polysaccharides obtained from Dendrobium for treating an allergic disease or for reducing airway-remodeling caused by inflammation. ... | 05/03/2011 |
| 7932236 | Glycolipids Novel synthetic gangliosides and pharmaceutical compositions containing such synthetic gangliosides are described. Methods of making the novel synthetic ganglioside compounds and compositions as well as their use in the field of neuroprotection is also described. | 04/26/2011 |
| 7932237 | Pharmaceutical compositions for use in the treatment of wounds A pharmaceutical composition that can be used in the treatment of wounds, comprising at least a sulfated polysaccharide and wherein the polysaccharide/s are in the form of solids as powder, flakes or sheets obtained through a lyophylization process. Particularly, th... | 04/26/2011 |
| 7928088 | Th1 cell differentiation accelerator The present invention provides an agent for promoting human Th1 cell differentiation and an agent for suppressing human Th2 cell differentiation, comprising lipoarabinomannans and/or lipomannans derived from BCG cell bodies. The agent of the present invention is use... | 04/19/2011 |
| 7928087 | Cosmetic compositions containing fructan and a cationic polymer and their uses The invention concerns novel cosmetic compositions comprising in a cosmetically acceptable medium, at least a fructan, at least a cationic polymer. Said composition provides a flow texture to cosmetic compositions, said compositions are easily rinsed. Hair treated w... | 04/19/2011 |
| 7923437 | Water soluble β-glucan, glucosamine, and N-acetylglucosamine compositions and methods for making the same Glucosamine, N-acetylglucosamine and β-glucan compositions suitable for human or animal consumption or use are disclosed. The glucosamine, N-acetylglucosamine and β-glucan compositions are derived from fungal biomass containing chitin. Various methods of producing... | 04/12/2011 |
| 7919480 | Polymers having covalently bound antibiotic agents An antimicrobial composition comprising: a complex of a polysaccharide covalently bonded with an antibiotic. A medical device having an antimicrobial composition comprising: a complex of an oxidized regenerated cellulose covalently bonded with gentamicin. ... | 04/05/2011 |
| 7919479 | Antiadhesive carbohydrates Provided is a pharmaceutical or dietetic product, which serves for reducing and/or blocking the adhesion of pathogenic substances and organisms to eucaryontic cells, in particular mammal cells. Said preparation contains at least one carbohydrate having an uronic aci... | 04/05/2011 |
| 7906492 | Therapy-enhancing glucan A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal, and at le... | 03/15/2011 |
| 7902170 | Influenza virus binding, sialylated oligosaccharide substance and use thereof The present invention is directed to human influenza virus binding substance containing at least one oligosaccharide chain, which comprises a terminal NeuNAcα6 linked to: (a) a linear or branched polylactosamine type structure consisting of at least three lactosami... | 03/08/2011 |
| 7902171 | Composition for treating inflammatory diseases The present invention relates to the use of hyaluronic acid for treating inflammatory diseases, in particular skin or mucous membrane diseases. ... | 03/08/2011 |
| 7902172 | Method of promoting bone growth with hyaluronic acid and growth factors A bone growth-promoting composition is provided comprising hyaluronic acid and a growth factor. The composition has a viscosity and biodegradability sufficient to persist at an intra-articular site of desired bone growth for a period of time sufficient to promote th... | 03/08/2011 |
